Literature DB >> 21549301

Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.

Sorel Goland1, Fahed Bitar, Kalgi Modi, Jordan Safirstein, Angela Ro, James Mirocha, Nudrat Khatri, Uri Elkayam.   

Abstract

BACKGROUND: Baseline left ventricular ejection fraction (LVEF) has been shown to be associated with likelihood of recovery in patients with peripartum cardiomyopathy (PPCM). The clinical relevance of this association for individual patients is unclear. METHODS AND
RESULTS: We analyzed baseline parameters of LVEF in 187 PPCM patients with ≥6 months follow-up data in an attempt to detect the value of baseline LVEF as a predictor of early recovery or persistence of severe LV dysfunction. Recovery of LV function (LVEF ≥50%) at 6 months after diagnosis was found in 115 patients (61%). Multivariate analysis identified baseline LVEF >30% as a significant predictor for recovery (odds ratio 5.2, 95% confidence interval 1.96-7.70; P > .0001). Recovery of LV function was 6.4-fold higher in women with baseline LVEF ≥ 30% (group III) and 3.9-fold higher in women with LVEF 20%-29% (group II) compared with those with LVEF 10%-19% (group I). Failure to achieve full recovery was seen in 63% of group I patients, 32% of group II (P = .03), and 21% of group III (P = .02 vs group I). Failure to achieve LVEF ≥30% was seen in 30% of group I patients and 13% of group II (P = .09).
CONCLUSIONS: Early recovery in patients with PPCM is significantly related to the degree of myocardial insult at time of diagnosis. Baseline LVEF however, has a limited sensitivity for prediction of failure to improve in individual patients and can not be used as an indication for premature use of aggressive therapy including devices or cardiac transplantation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21549301     DOI: 10.1016/j.cardfail.2011.01.007

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  24 in total

1.  Importance of Early Diagnosis in Peripartum Cardiomyopathy.

Authors:  Jennifer Lewey; Lisa D Levine; Michal A Elovitz; Olga C Irizarry; Zoltan Arany
Journal:  Hypertension       Date:  2019-11-11       Impact factor: 10.190

Review 2.  Echocardiography in Pregnancy: Part 1.

Authors:  Shuang Liu; Uri Elkayam; Tasneem Z Naqvi
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

3.  Article Commentary: Acute Heart Failure: Is it Peripartum Cardiomyopathy or Not?

Authors:  Katrin Bachelier-Walenta; Denise Hilfiker-Kleiner; Karen Sliwa
Journal:  Obstet Med       Date:  2013-03-01

4.  Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.

Authors:  Julie Damp; Michael M Givertz; Marc Semigran; Rami Alharethi; Gregory Ewald; G Michael Felker; Biykem Bozkurt; John Boehmer; Jennifer Haythe; Hal Skopicki; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; John Gorcsan; Sarosh Rana; Zoltan Arany; James D Fett; Dennis M McNamara
Journal:  JACC Heart Fail       Date:  2016-03-09       Impact factor: 12.035

5.  Management of peripartum cardiomyopathy.

Authors:  Garrick C Stewart
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 6.  The Use of Echocardiography and Advanced Cardiac Ultrasonography During Pregnancy.

Authors:  Anna C O'Kelly; Garima Sharma; Arthur Jason Vaught; Sammy Zakaria
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-21

Review 7.  Peripartum cardiomyopathy: a contemporary review.

Authors:  Tina Shah; Sameer Ather; Chirag Bavishi; Arvind Bambhroliya; Tony Ma; Biykem Bozkurt
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 8.  Peripartum cardiomyopathy: A puzzle closer to solution.

Authors:  James D Fett
Journal:  World J Cardiol       Date:  2014-03-26

9.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Authors:  Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

10.  Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine.

Authors:  Piercarlo Ballo; Irene Betti; Giuseppe Mangialavori; Leandro Chiodi; Gherardo Rapisardi; Alfredo Zuppiroli
Journal:  Case Rep Med       Date:  2012-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.